Camden Ppty Tr Financials
Camden Ppty Tr (CPT) reported $13.0M in revenue for fiscal year 2025, up 81.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Camden’s operating model is cash-generative but capital-hungry, with distributions and buybacks absorbing most of internally produced funds.
Operating cash flow kept rising to$827M in FY2025 even as cash on hand shrank to$25.2M , which means the business is not stockpiling liquidity; it is continually recycling cash into asset investment, shareholder distributions, and other capital uses. That pattern matters because long-term debt moved up while equity moved down over the last two years, the signature of an asset-heavy funding model where cash is produced steadily but quickly re-allocated.
Earnings understate the cash engine: FY2025 depreciation was
Borrowing costs are climbing with leverage: interest expense reached
Financial Health Signals
Scored against REITs for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Camden Ppty Tr's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Camden Ppty Tr, and counted as zero in the overall score.
Not available for Camden Ppty Tr, and counted as zero in the overall score.
Camden Ppty Tr passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Camden Ppty Tr generates $2.15 in operating cash flow ($826.6M OCF vs $384.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Camden Ppty Tr generated $13.0M in revenue in fiscal year 2025. This represents an increase of 81.7% from the prior year.
Camden Ppty Tr reported $384.5M in net income in fiscal year 2025. This represents an increase of 135.4% from the prior year.
Camden Ppty Tr earned $3.54 per diluted share (EPS) in fiscal year 2025. This represents an increase of 136.0% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Camden Ppty Tr held $25.2M in cash against $3.9B in long-term debt as of fiscal year 2025.
Camden Ppty Tr paid $4.20 per share in dividends in fiscal year 2025. This represents an increase of 1.9% from the prior year.
Not reported for fiscal year 2025.
Margins & Returns
Camden Ppty Tr's ROE was 8.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 5.3 percentage points from the prior year.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for fiscal year 2025.
Not shown for fiscal year 2025: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Camden Ppty Tr spent $270.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 441.3% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
CPT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.1M | $13.0M+81.7% | $7.1M+106.8% | $3.5M-33.5% | $5.2M-50.7% | $10.5M-2.5% | $10.8M+24.2% | $8.7M+20.3% | $7.2M-11.6% | $8.2M-99.1% | $876.4M | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | $566.7M+1.4% | $558.8M+1.8% | $548.9M+10.2% | $498.1M+19.4% | $417.0M+5.6% | $394.8M+7.8% | $366.3M+6.6% | $343.6M+4.5% | $328.7M | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | -$553.7M-0.4% | -$551.7M-1.1% | -$545.5M-10.7% | -$492.9M-21.3% | -$406.5M-5.9% | -$384.0M-7.4% | -$357.7M-6.3% | -$336.3M-4.9% | -$320.6M | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $80.5M | $79.3M+9.6% | $72.4M+15.8% | $62.5M+3.5% | $60.4M+1.8% | $59.4M+10.7% | $53.6M+0.8% | $53.2M+4.9% | $50.7M+0.3% | $50.6M+6.7% | $47.4M+2.6% | $46.2M-9.4% | $51.0M+25.7% | $40.6M+8.1% | $37.5M+5.8% | $35.5M |
| Interest Expense | $147.9M | $138.2M+6.5% | $129.8M-2.7% | $133.4M+17.6% | $113.4M+16.6% | $97.3M+6.3% | $91.5M+13.4% | $80.7M-4.2% | $84.3M-2.9% | $86.8M-6.9% | $93.1M-4.3% | $97.3M+2.5% | $94.9M-4.9% | $99.8M-4.3% | $104.2M-7.3% | $112.4M |
| Income Tax | N/A | $4.0M+37.9% | $2.9M-21.6% | $3.7M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $326.2M | $384.5M+135.4% | $163.3M-59.5% | $403.3M-38.3% | $653.6M+115.1% | $303.9M+145.3% | $123.9M-43.6% | $219.6M+40.7% | $156.1M-20.5% | $196.4M-76.0% | $819.8M+228.8% | $249.3M-14.6% | $292.1M-13.2% | $336.4M+18.7% | $283.4M+473.9% | $49.4M |
| EPS (Diluted) | — | $3.54+136.0% | $1.50-59.5% | $3.70-38.7% | $6.04+104.1% | $2.96+138.7% | $1.24-44.1% | $2.22+36.2% | $1.63-23.5% | $2.13-76.5% | $9.05+227.9% | $2.76-15.6% | $3.27-13.5% | $3.78+14.5% | $3.30+400.0% | $0.66 |
Not reported in any period shown, so not listed: R&D Expenses, Operating Income.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CPT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.0B+2.2% | $8.9B-5.7% | $9.4B+0.6% | $9.3B+16.9% | $8.0B+10.8% | $7.2B+6.7% | $6.7B+8.5% | $6.2B+0.7% | $6.2B+2.4% | $6.0B-0.2% | $6.0B-0.1% | $6.0B+7.3% | $5.6B+4.6% | $5.4B+16.5% | $4.6B |
| Cash & Equivalents | $25.2M+19.8% | $21.0M-91.9% | $259.7M+2329.9% | $10.7M-98.3% | $613.4M+45.9% | $420.4M+1713.5% | $23.2M-32.6% | $34.4M-90.7% | $368.5M+55.2% | $237.4M+2135.7% | $10.6M-93.1% | $153.9M+765.0% | $17.8M-33.3% | $26.7M-51.7% | $55.2M |
| Total Liabilities | $4.6B+12.2% | $4.1B-5.2% | $4.3B+1.4% | $4.3B+15.1% | $3.7B+0.8% | $3.7B+20.9% | $3.0B+9.5% | $2.8B+6.5% | $2.6B-8.5% | $2.9B-6.8% | $3.1B-0.7% | $3.1B+9.3% | $2.8B+2.4% | $2.8B+2.3% | $2.7B |
| Long-Term Debt | $3.9B+11.9% | $3.5B-6.2% | $3.7B+0.9% | $3.7B+16.1% | $3.2B+0.1% | $3.2B+25.5% | $2.5B+8.7% | $2.3B+5.3% | $2.2B-11.1% | $2.5B-9.0% | $2.7B-0.7% | $2.7B+8.4% | $2.5B+0.8% | $2.5B+3.2% | $2.4B |
| Total Equity | $4.4B-6.7% | $4.7B-6.1% | $5.0B-0.1% | $5.0B+18.8% | $4.2B+21.8% | $3.4B-5.1% | $3.6B+9.6% | $3.3B-2.8% | $3.4B+13.0% | $3.0B+7.0% | $2.8B0.0% | $2.8B+4.6% | $2.7B+5.0% | $2.6B+45.7% | $1.8B |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Retained Earnings.
CPT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $807.4M | $826.6M+6.7% | $774.9M-2.5% | $795.0M+6.7% | $744.7M+29.0% | $577.5M+11.2% | $519.3M-6.5% | $555.6M+10.3% | $503.7M+15.9% | $434.7M-1.9% | $443.1M+4.7% | $423.2M+1.1% | $418.5M+3.5% | $404.3M+24.7% | $324.3M+32.4% | $244.8M |
| Investing Cash Flow | -$644.8M | -$499.5M-75.1% | -$285.2M-124.4% | -$127.1M+91.3% | -$1.5B-81.0% | -$804.4M-87.2% | -$429.6M+45.8% | -$792.4M-23.6% | -$640.9M-237.8% | -$189.8M-127.5% | $690.4M+335.4% | -$293.2M+10.2% | -$326.6M-26.1% | -$259.0M+50.9% | -$527.7M-181.6% | -$187.4M |
| Financing Cash Flow | -$148.4M | -$322.0M+55.6% | -$725.5M-73.9% | -$417.2M-479.5% | $109.9M-73.9% | $421.4M+37.1% | $307.3M+39.2% | $220.7M+212.0% | -$197.0M-74.5% | -$112.9M+87.5% | -$904.2M-230.9% | -$273.2M-728.4% | $43.5M+128.2% | -$154.2M-188.1% | $174.9M+201.2% | -$172.9M |
| Dividends Paid | $458.5M | $460.9M+2.2% | $451.0M+3.7% | $434.9M+9.6% | $396.8M+15.7% | $343.0M+2.9% | $333.4M+5.1% | $317.3M+6.5% | $298.0M+6.1% | $280.8M-57.7% | $663.4M+162.1% | $253.1M+7.0% | $236.5M+7.5% | $220.1M+16.4% | $189.0M+24.2% | $152.2M |
| Share Buybacks | $703.7M | $270.7M+441.3% | $50.0M | $0 | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CPT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -4270.4% | -7729.7% | -15806.1% | -9500.6% | -3859.6% | -3555.8% | -4112.8% | -4651.5% | -3920.8% | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 2964.9% | 2288.0% | 11686.7% | 12598.5% | 2885.6% | 1147.3% | 2525.6% | 2159.2% | 2402.4% | 93.5% | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | 8.8%+5.3pp | 3.5%-4.6pp | 8.1%-5.0pp | 13.1%+5.9pp | 7.2%+3.6pp | 3.6%-2.5pp | 6.0%+1.3pp | 4.7%-1.1pp | 5.8%-21.4pp | 27.2%+18.3pp | 8.8%-1.5pp | 10.4%-2.1pp | 12.5%+1.4pp | 11.1%+8.3pp | 2.8% |
| Return on Assets | 4.3%+2.4pp | 1.8%-2.5pp | 4.3%-2.7pp | 7.0%+3.2pp | 3.8%+2.1pp | 1.7%-1.5pp | 3.3%+0.7pp | 2.5%-0.7pp | 3.2%-10.4pp | 13.6%+9.5pp | 4.1%-0.7pp | 4.8%-1.1pp | 6.0%+0.7pp | 5.3%+4.2pp | 1.1% |
| Debt-to-Equity | 0.89+0.1x | 0.750.0x | 0.750.0x | 0.740.0x | 0.76-0.2x | 0.92+0.2x | 0.700.0x | 0.70+0.1x | 0.65-0.2x | 0.82-0.1x | 0.970.0x | 0.970.0x | 0.940.0x | 0.98-0.4x | 1.38 |
Not reported in any period shown, so not listed: Operating Margin, Current Ratio, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Net Margin.
Similar Companies
Where Camden Ppty Tr Ranks
Frequently Asked Questions
What is Camden Ppty Tr's annual revenue?
Camden Ppty Tr (CPT) reported $13.0M in total revenue for fiscal year 2025. This represents a 81.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Camden Ppty Tr's revenue growing?
Camden Ppty Tr (CPT) revenue grew by 81.7% year-over-year, from $7.1M to $13.0M in fiscal year 2025.
Is Camden Ppty Tr profitable?
Yes, Camden Ppty Tr (CPT) reported a net income of $384.5M in fiscal year 2025.
How much debt does Camden Ppty Tr have?
As of fiscal year 2025, Camden Ppty Tr (CPT) had $25.2M in cash and equivalents against $3.9B in long-term debt.
Does Camden Ppty Tr pay dividends?
Yes, Camden Ppty Tr (CPT) paid $4.20 per share in dividends during fiscal year 2025.
What is Camden Ppty Tr's return on equity (ROE)?
Camden Ppty Tr (CPT) has a return on equity of 8.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Camden Ppty Tr's operating cash flow?
Camden Ppty Tr (CPT) generated $826.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Camden Ppty Tr's total assets?
Camden Ppty Tr (CPT) had $9.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Camden Ppty Tr's debt-to-equity ratio?
Camden Ppty Tr (CPT) had a debt-to-equity ratio of 0.89 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Camden Ppty Tr's return on assets (ROA)?
Camden Ppty Tr (CPT) had a return on assets of 4.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Camden Ppty Tr's Piotroski F-Score?
Camden Ppty Tr (CPT) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Camden Ppty Tr's earnings high quality?
Camden Ppty Tr (CPT) has an earnings quality ratio of 2.15x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Camden Ppty Tr?
Camden Ppty Tr (CPT) scores 53 out of 100 on our Financial Health Score, indicating moderate standing within its REITs peer group. The score is a 0-100 composite of six dimensions (FFO Margin, FFO Growth, Leverage, Interest Cov., AFFO Margin, Dividend Cov.), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.